Who Just Raised

Evia Bio, Inc.

Minneapolis, MN · Biotechnology

Evia Bio, Inc. is a biotechnology company based in Minneapolis, Minnesota. In a Form D filed with the SEC on September 28, 2026, it reported raising $5,453,532 from 19 investors as part of an offering of up to $5,453,532. The first sale in the offering took place on September 14, 2026.

100% of the $5.5M offering sold so far

Evia Bio’s cryopreservation technology enables the entire Cell Therapy supply chain with high product yield, efficacy, and safety. You don’t have to settle for less.

Website
eviabio.com
Amount raised
$5,453,532
Offering size
$5,453,532
Investors so far
19
First sale
September 14, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Minneapolis, Minnesota
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $5,453,532 $5,453,532 19 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Minnesota

Company Location Sector Raised Target Filed
Surgicare of Minneapolis, Ltd. St. Louis Park, MN Health Care — $342K
Pelvital USA, Inc. Eagan, MN Health Care $520K $4M
ProEncia Biotechnology Inc. Woodbury, MN Health Care $1.5M $2M
InSitu Biologics, Inc. Oakdale, MN Health Care $1.3M $2.5M
Pelva Health Corp Edina, MN Health Care $30K $2M
Gentle Caring Mind Healthcare LLC Coon Rapids, MN Health Care $50K $200K